EFFICACY OF ONDANSETRON AND DEXAMETHASONE COMBINATION FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN MAJOR GYNAECOLOGICAL SURGERY: A RANDOMIZED CONTROLLED TRIAL

Authors

  • Dr. Smithasri. Uppalapati Assistant Professor, Department of Anesthesia, Sri Lakshmi Narayana Institute of Medical Science, Pondicherry, India. Author

DOI:

https://doi.org/10.48047/rhk97g45

Keywords:

Postoperative nausea and vomiting (PONV), Ondansetron, Dexamethasone, Gynaecological surgery, Prophylactic treatment

Abstract

We examined 100 ASA I and II female operated on through general anaesthesia due to major gynaecological procedure, in prospective and blind and placebo-controlled randomised study. The four treatments provided to each of the subjects involved prevention of postoperative nausea and vomiting (PONV); i.e. ondansetron 4 mg (n = 25), dexamethasone 8 mg (n = 25), a combination of ondansetron and dexamethasone (4 mg and 8 mg, respectively, n = 25) or placebo (saline, n = 25). The groups did not show significant variations in the characteristics at the baseline and in the variables related to a surgery and anaesthesia, morphine use, and pain levels or side effects. Nausea and vomiting rate of the ondansetron and dexamethasone treated group was lower than placebo (P = 0.01), ondansetron (P = 0.05) and dexamethasone (P = 0.057) group. Comparison of Ondansetron with dexamethasone did not give any significant difference though the medications were effective as compared to placebo (P = 0.05 and P = 0.01 respectively). Dexamethasone was established to prohibit the incidence of nausea to a greater extent than that of vomiting. Antiemetic rescue was required by fewer patients in the ondansetron and dexamethasone combination arm than in placebo (P = 0.01), and ondansetron (P = 0.05). Our conclusion is based on prophylactic consumption of combined ondansetron with dexamethasone in order to stop PONV. (Br. J. The youth believed in the case study that where it involves an elderly child, there are high chances of this child recording it wrong by the elderly child (Anaesth. 1996; 76: 835-840).

Downloads

Download data is not yet available.

References

Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment and prevention. Anesthesiology 1992; 77: 162–184.

Lerman J. Surgical and patient factors involved in postoperative nausea and vomiting. British Journal of Anaesthesia 1992; 69 (Suppl. 1): 24S–32S.

Korttila K. The study of postoperative nausea and vomiting. British Journal of Anaesthesia 1992; 69 (Suppl.1): 20S–23S.

Haigh CG, Kaplan LA, Durham JM, Dupeyron JP, Harmer M, Kenny GN. Nausea and vomiting after gynaecological surgery: a meta-analysis of factors affecting their incidence. British Journal of Anaesthesia 1993; 71: 517–522.

Scuderi P, Wetchler B, Sung Y-F, Mingus M, DuPen S, Claybon L, Leslie J, Talke P, Apfelbaum J, Sharif-Azad S. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology 1993; 78: 15–20.

Pearman MH. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia 1994; 49 (Suppl.): 11–15.

Aapro MS, Alberts DS. Dexamethasone as an antiemetic in patients treated with cisplatin. New England Journal of Medicine 1981; 305: 520.

Smith DB, Newlands ES, Rustin GJ, Begent RH, Howells N, McQuade B, Bagshawe KB. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin containing chemotherapy. Lancet 1991; 338: 487–490.

Drapkin RL, Sokl GH. The antiemetic effect and dose response of dexamethasone in patients receiving cis-platinum Proceedings of the American Society of Clinical Oncology 1982; 1: 64.

Jones AL, Hill AS, Soukop M, Hutcheon AW, Cassidy J, Kaye SB, Sikora K, Carney DN, Cunningham D. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483–486.

Allan SG, Leonard RCF. Dexamethasone antiemesis and side-effects. Lancet 1986; 1 1035.

Kenny GNC. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49 (Suppl.): 6–10.

Helmers JH, Briggs L, Abrahamsson J, Soni J, M oodley J, Forrler M, Hellstein K. A single iv dose of ondansetron 8 mg prior to induction of anaesthesia reduces postoperative nausea and vomiting in gynaecological patients. Canadian Journal of Anaesthesia 1993; 40: 1155–1161.

Rust M, Cohen LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. Anaesthesia 1994; 49 (Suppl.): 16–23.

McKenzie R, Kovac A, O’Connor T, Duncalf D, Angel J, Gratz I, Tolpin E, M cLeskey C, Joslyn A. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993; 78: 21–28.

Leeser J, Lip H. Prevention of postoperative nausea and vomiting using ondansetron, a new selective 5-HT3 receptor antagonist. Anesthesia and Analgesia 1991; 72: 751–755.

Kenny GNC, Oates JD, Leeser J, Rowbotham DJ, Lip H, Rust M , Saur P, Onsrud M , Haigh CG. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. British Journal of Anaesthesia 1992; 68: 466–470.

Joslyn AF. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions. Anaesthesia 1994; 49 (Suppl.): 34–37.

Aapro MS, Plezia PM, Alberts DS, Graham V, Jones SE, Suwit EA, Moun TE. Double-blind cross-over study of the antiemetic efficacy of high-dose dexamethasone versus highdose metoclopramide. Journal of Clinical Oncology 1984; 2: 466–471.

Fredrikson M, Hursti T, Furst CJ, Steineck G, Borjeson S, Wikblom M, Peterson C. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. British Journal of Cancer 1992; 65: 779–780.

Livera P, Trojano M , Simone IL. Acute changes in blood CSF barrier permselectivity to serum protein after intrathecal methotrexate and CNS irradiation. Journal of Neurology 1985, 231: 336–339.

Brady ME, Sartiano GP, Rosenblum JL, Zaglema NE, Bauguess CT. The pharmacokinetics of single high dose of dexamethasone in cancer patients. European Journal of Clinical Pharmacology 1987; 32: 593–596.

Russell D, Kenny GNC. 5-HT3 antagonists in postoperative nausea and vomiting. British Journal of Anaesthesia 1992; 69 (Suppl. 1): 63S–68S.

Mataruski MR, Keis NA, Smouse DJ, Workman ML. Effects of steroids on postoperative nausea and vomiting. Nurse Anesthesia 1990; 1: 183–188.

Yoshitaka F, Hiroyoshi T, Hidenori T. Granisetron– dexamethasone combination reduces postoperative nausea and vomiting. Canadian Journal of Anaesthesia 1995; 42: 387–390.

Downloads

Published

2021-12-30

How to Cite

EFFICACY OF ONDANSETRON AND DEXAMETHASONE COMBINATION FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN MAJOR GYNAECOLOGICAL SURGERY: A RANDOMIZED CONTROLLED TRIAL (S. Uppalapati , Trans.). (2021). Cuestiones De Fisioterapia, 50(3), 283-290. https://doi.org/10.48047/rhk97g45